Nature´s Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1
(WorldNews Health)

December 12, 2017 CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ( Resverlogix or the Company ) (TSX:RVX) announced today that a recent Nature Scientific Reports has published a 12 page publication on BET (bromodomain and extra-terminal) inhibitors; RVX-208 (apabetalone) and PFI-1 owned by Resverlogix and Pfizer, respectively. The publication by Lu et al, BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency , (Scientific Reports 7, Article number: 16646, https://www.nature.com/articles/s41598-017-16816-1)...